SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-002075
Filing Date
2018-03-23
Accepted
2018-03-23 16:22:44
Documents
5
Period of Report
2018-04-24
Effectiveness Date
2018-03-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2234992zdef14a.htm DEF 14A 662636
2 G114007.JPG g114007.jpg GRAPHIC 6153
3 G303095.JPG g303095.jpg GRAPHIC 4011
4 G22122BGI001.GIF g22122bgi001.gif GRAPHIC 94367
5 G22122BGI002.GIF g22122bgi002.gif GRAPHIC 66896
  Complete submission text file 0001047469-18-002075.txt   900460
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 18710381
SIC: 2834 Pharmaceutical Preparations